Rate and predictors of mucosal healing in patients with inflammatory bowel disease treated with anti-TNF-alpha antibodies.
Mucosal healing (MH) is an important treatment goal in patients with inflammatory bowel disease (IBD), but factors predicting MH under medical therapy are largely unknown. In this study, we aimed to characterize predictive factors for MH in anti-TNF-alpha antibody-treated IBD patients.We retrospecti...
Main Authors: | Florian Beigel, Matthias Deml, Fabian Schnitzler, Simone Breiteneicher, Burkhard Göke, Thomas Ochsenkühn, Stephan Brand |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4059645?pdf=render |
Similar Items
-
Analysis of IL12B gene variants in inflammatory bowel disease.
by: Jürgen Glas, et al.
Published: (2012-01-01) -
The NOD2 p.Leu1007fsX1008 mutation (rs2066847) is a stronger predictor of the clinical course of Crohn's disease than the FOXO3A intron variant rs12212067.
by: Fabian Schnitzler, et al.
Published: (2014-01-01) -
IRGM variants and susceptibility to inflammatory bowel disease in the German population.
by: Jürgen Glas, et al.
Published: (2013-01-01) -
Efficiency of Orexin-A for Inflammatory Flare and Mucosal Healing in Experimental Colitis: Comparison with the Anti-TNF Alpha Infliximab
by: Anne Blais, et al.
Published: (2023-05-01) -
Mucosal healing in inflammatory bowel diseases: a systematic review.
by: Neurath, M, et al.
Published: (2012)